The contents of the above applications are all incorporated by reference as if fully set forth herein in their entirety.
The present invention relates to the evagination and the grasping, fixating and fastening of a part in the human body (referred to hereinafter as “repositioning”). More particularly, the invention relates to a device that permits to perform a procedure that repositions the left atrial appendage of the heart.
Atrial rhythm abnormalities are associated with the development of blood clots in the atrial chamber, which can result in the formation of thrombus and emboli which may (among other things) cause brain stroke. The left atrial appendage (“LAA”) is particularly susceptible to clot formation. Several approaches were developed to reduce the risk of clot formation in the LAA, mainly consisting in physically separating or occluding the LAA from the left atrium. Said devices reduce the risk of blood clots in the LAA and/or obstruct or filter the flow of clots from the LAA into the atrium. One example of the separation devices are permanently-implanted occluders. Permanently-implanted occluders (e.g., Watchman®) are usually introduced transseptally up to the LAA by a delivery catheter and then the device is anchored at the desired location by fixation barbs or other methods.
An example of such an occlusion device is shown in
A second example of physical separation of LAA is described in U.S. Pat. No. 7,427,279, which discloses a closure catheter comprising deployable tissue anchors. The device is to be inserted up to the LAA. Once located properly, the anchors are deployed into the surrounding tissue and draw the tissue radially inwardly to close the LAA cavity.
A third example of physical separation of LAA are permanently implanted clip (e.g., The AtriClip™ LAA Exclusion System—http://www(dot)atricure(dot)com) which contains an LAA Clip for open occlusion of the heart's left atrial appendage. The Clip is pre-loaded on a disposable Clip applier. Said clips are located extraluminally, and require open-chest surgery.
Blood clot formation in the LAA is managed also by anticoagulant therapies, such as Warfarin (Coumadin). Said therapies cause significant complications in 1-2% of patients a year.
Although a variety of procedures has been suggested for overcoming the problem, all procedures known in the art are either long and complex, or present severe dangers resulting from perforation of the cardiac (left atrial and LAA) wall, or from the voluntary or involuntary removal of portions of the LAA, and many present both drawbacks. Therefore, so far the art has failed to provide a simple and safe method to perform the closure of the LAA, and no attempts have been made to evaginate it as a stage of a closure procedure.
It is an object of the invention to provide a method and apparatus for repositioning a body part.
It is another object of the invention to provide a device that permits to perform a medical procedure by which there is evagination and then constant fixation in the left atrium of the LAA, which can be safely performed without the danger of damaging the LAA tissue.
It is yet another object of the invention to provide a device suitable for carrying out a procedure at the end of which the repositioned LAA is covered by not-thrombogenic endocardium and cannot harbor blood clots.
Other objectives and advantages of the invention will become apparent as the description proceeds.
The invention in one aspect relates to a device for manipulating a body part, comprising:
According to one embodiment of the invention the suction channel terminates in a concave holder, such as, e.g., a holder selected from a cup, a cone, or other semi-spherical shape. The holder is preferably—but not limitatively—made of flexible material.
The device of the invention may further integrally comprise fastening means, or fastening means may be provided separately. In one embodiment of the invention the fastening means are actuatable from the elongated guide instrument. In another embodiment of the invention the fastening means comprise, at or near its proximal end, a string or the like flexible looped element. The flexible looped element may be conveniently provided in its pre-deployed position, such that it is looped around the axis of the elongated guide instrument.
In one embodiment of the invention the fastening means comprise a clipping or clamping fastener. In another embodiment of the invention the fastening means comprise a staple.
In a particularly interesting embodiment of the invention the device is suitable to reposition a body part, which is the left atrial appendage of a heart.
The suction channel can be also used for aspiring blood clots, especially those located in the LAA.
In another embodiment of the invention the device is suitable to secure and isolate polyps in the GI tract.
Also encompassed by the invention is a device, which is coupled to fastening means, which are not integral therewith. In one embodiment of such device, the fastening means comprise filling means suitable to fill the void created in the outer part of a heart, by the repositioning of the left atrial appendage of the heart. Suitable filling means comprise, e.g., a biocompatible glue.
The invention is also directed to a method for repositioning a body part, comprising positioning an elongated guide instrument provided with a tip in close juxtaposition with a tissue at a desired location, wherein said guide instrument is provided with a suction channel terminating in or near said tip and with fastening means actuatable from said elongated guide instrument.
In the drawings:
All other figures schematically illustrates the operation of a device according to the invention, wherein:
The present invention relates to a catheter-based device and method for the evagination and the grasping, fixating and fastening (collectively referred to herein as “repositioning”) of a body part. In a particularly important application, said body part is the intraatrial left atrial appendage (LAA). Although the invention is in no way limited to use in the LAA, this procedure will be used in the description to follow, to illustrate the device of the invention and its use.
The procedures described herein can be carried out under vision, employing vision techniques such as fluoroscopy and transesophageal echo.
In a specific embodiment of the invention, the device comprises an elongated flexible guide instrument, a suction device and a device suitable to deploy a fastening accessory. Other devices regularly used in endoscopic surgery, such as light sources, cameras etc. can be also carried in the guide instrument, and such conventional apparatus is not described herein in detail, for the sake of brevity.
In a particular embodiment of the invention, the suction device and the device to apply a fastening accessory are located in the lumen of the guide instrument. Said fastening accessory can be of any suitable type and can be made of one piece or of a plurality of pieces. In one embodiment of the invention, the fastening accessory comprises one or more clips. In another embodiment the fastening accessory comprises one or more loops. Different fastening accessories can also be combined and various suitable accessories will be easily evident to the skilled person from the description to follow.
Transapex or transaortal or transatnial external through the pericard Transseptal access to the LLA is usually achieved by introducing a transseptal catheter through the femoral or jugular vein, and advancing the catheter transluminally into the right atrium. After locating the catheter in the right atrium, a long hollow needle is inserted transseptally by force through the fossa ovalis until attaining the left atrium, as seen at 100 in
In one embodiment of the invention the catheter is provided at its tip with a suction channel that terminates in a concave holder selected from a cup, a cone or other semi-spherically shaped device, which is expanded after reaching the left atrium, thus preventing possible atrial and/or appendage wall perforation by the catheter tip. The suction channel can be also used for aspiring blood clots, especially those located in the LAA. Alternatively, a catheter tip can be made of any soft material that is less prone to cause perforation. As will be apparent to the skilled person, this safety feature (or an alternative one) is desirable but the invention can be carried out without it. The catheter is then inserted into the LAA (
At the end of the procedure the LAA is repositioned into the left atrium and held by a fastening accessory. When operating according to the embodiment described above, as well as with other embodiments of the invention, no pins, hooks or other sharp and penetrating parts on the atrial wall are used, and no penetration of atrial wall outside to pericardium is performed.
When operating according to the invention, suction, of up to 1 atmosphere can be employed without substantial fear of damage to the tissue. The force applied to fixate the appendage base with a lasso or clip must be calculated so as not to impart damage. For instance, said force can be up to 3 kg, preferably 2 kg, provided the wire of lasso is at least 0.7 mm nitinol in diameter and the clip bar of the similar size at least are safe.
Experimental Procedure and Selection of Operating Conditions
The above-illustrated procedure was carried out, in vivo, using a nitinol wire of 0.7 mm diameter as a lasso that created the loop 206 of the figures. As said, forces of 2-3 Kg were applied without any damage to the LAA tissue. However, should a practitioner wish to employ different operating conditions than the above, the following procedure should be followed:
1. Selection of Standard Substrate
A standard substrate, such as a silicone cylinder of 1 cm diameter is selected. Any other suitable soft material can be employed.
2. Determination of Standard Penetration Depth
The standard penetration depth with the selected material is determined by wrapping a lasso made of 0.7 mm diameter nitinol wire and applying a force of 2 Kg on the wire. When application of the force is completed the wire is removed and the depth to which it has penetrated the selected standard substrate is measured.
3. Determination of Alternative Operating Conditions
To determine a suitable set of operating conditions with a different type of wire, the selected wire is wrapped around the selected standard substrate as in 2 above, and forces of different magnitude are applied. The depth of penetration with each force applied is then measured. The force to be used with the newly selected wire is that which created a penetration depth essentially of the same magnitude as obtained in (2) above.
In an alternative embodiment of the invention fastening means are used, which are not integral with the guide introduced into the heart. In such a device the fastening means comprise filling means suitable to fill the void created in the outer part of a heart, by the repositioning of the left atrial appendage of the heart. Such filling means comprise, e.g., a biocompatible glue.
An alternative fixation method involves fixating the evaginated appendage in its position achieved after suction and traction, by anchoring it to the cardiac wall, for example to the interatrial septum.
In an alternative embodiment of the invention the device of the invention can be used in endoscopy of gastrointestinal, urinary, airway or any other tract to grasp (with suction) and to put a loop (clip) on polyps, tumors etc. Such uses also form a part of the invention.
The skilled person will devise many other additional uses of the device of the invention. For instance, suction can be applied through the suction channel to remove blood clots from the LAA, prior to any other operations.
As will be apparent to the skilled person from the above description, the invention affords the means for performing an effective and safe procedure, which was not available in the art before the invention. Although the invention has been described using a preferred embodiment by way of illustration, the skilled person will easily appreciate the many alternative ways in which the invention can be carried out.
All publications, patents and patent applications mentioned in this specification are herein incorporated in their entirety by reference into the specification, to the same extent as if each individual publication, patent or patent application was specifically and individually indicated to be incorporated herein by reference. In addition, citation or identification of any reference in this application shall not be construed as an admission that such reference is available as prior art to the present invention. To the extent that section headings are used, they should not be construed as necessarily limiting. In addition, any priority document(s) of this application is/are hereby incorporated herein by reference in its/their entirety.
Number | Date | Country | Kind |
---|---|---|---|
218737 | Mar 2012 | IL | national |
This application is a continuation of U.S. patent application Ser. No. 14/232,573 filed on Jan. 13, 2014, which is National Phase of PCT Patent Application No. PCT/IL2012/000278 having International Filing Date of Jul. 9, 2012, which claims the benefit of priority of Israel Patent Application No. 218737 filed on Mar. 19, 2012 and U.S. Provisional Patent Application No. 61/457,928 filed on Jul. 11, 2011.
Number | Name | Date | Kind |
---|---|---|---|
2235350 | Anderson | Mar 1941 | A |
5224497 | Ehlers | Jul 1993 | A |
5423830 | Schneebaum | Jun 1995 | A |
5792153 | Swain et al. | Aug 1998 | A |
6152936 | Christy | Nov 2000 | A |
6383198 | Hamilton | May 2002 | B1 |
7427279 | Frazier et al. | Sep 2008 | B2 |
8647367 | Kassab et al. | Feb 2014 | B2 |
8784469 | Kassab | Jul 2014 | B2 |
20010041914 | Frazier et al. | Nov 2001 | A1 |
20030158563 | McClellan et al. | Aug 2003 | A1 |
20040044364 | DeVries | Mar 2004 | A1 |
20050021016 | Malecki et al. | Jan 2005 | A1 |
20070043344 | McAuley | Feb 2007 | A1 |
20070083082 | Kiser et al. | Apr 2007 | A1 |
20070225734 | Bell et al. | Sep 2007 | A1 |
20080033241 | Peh | Feb 2008 | A1 |
20080255427 | Satake | Oct 2008 | A1 |
20080294175 | Bardsley et al. | Nov 2008 | A1 |
20080312664 | Bardsley et al. | Dec 2008 | A1 |
20090326518 | Rabin | Dec 2009 | A1 |
20100145361 | Francischelli et al. | Jun 2010 | A1 |
20100191279 | Kassab et al. | Jul 2010 | A1 |
20100312256 | Kassab et al. | Dec 2010 | A1 |
20110077672 | Fleischman et al. | Mar 2011 | A1 |
20110082495 | Ruiz | Apr 2011 | A1 |
20120035622 | Kiser et al. | Feb 2012 | A1 |
20140018831 | Kassab et al. | Jan 2014 | A1 |
20140171733 | Sternik | Jun 2014 | A1 |
20160106437 | van der Burg et al. | Apr 2016 | A1 |
20170065283 | Kassab et al. | Mar 2017 | A9 |
20190262003 | Kiser et al. | Aug 2019 | A1 |
20200100796 | Berger et al. | Apr 2020 | A1 |
Number | Date | Country |
---|---|---|
1579823 | Sep 2005 | EP |
WO 2008020975 | Feb 2008 | WO |
WO 2012103556 | Aug 2012 | WO |
WO 2013008231 | Jan 2013 | WO |
WO 2018178979 | Oct 2018 | WO |
Entry |
---|
Applicant-Initiated Interview Summary dated Nov. 3, 2017 From the US Patent and Trademark Office Re. U.S. Appl. No. 14/232,573. (3 pages). |
Communication Pursuant to Article 94(3) EPC dated Apr. 19, 2017 From the European Patent Office Re. Application No. 12811116.8. (9 Pages). |
Communication Pursuant to Article 94(3) EPC dated Oct. 31, 2018 From the European Patent Office Re. Application No. 12811116.8. (7 Pages). |
Communication Pursuant to Rules 161(2) and 162 EPC dated Feb. 27, 2014 From the European Patent Office Re. Application No. 12811116.8. (3 Pages). |
International Preliminary Report on Patentability dated Jan. 14, 2014 From the International Bureau of WIPO Re. Application No. PCT/IL2012/000278. (10 Pages). |
International Search Report and the Written Opinion dated Aug. 14, 2018 From the International Searching Authority Re. Application No. PCT/IL2018/050353. (22 Pages). |
International Search Report dated Nov. 11, 2012 From the International Searching Authority Re. Application No. PCT/IL2012/000278. (4 Pages). |
Invitation to Pay Additional Fees, Communication Relating to the Results of the Partial International Search and the Provisional Opinion dated Jun. 20, 2018 From the International Searching Authority Re. Application No. PCT/IL2018/050353. (16 Pages). |
Notice Of Allowance dated Jan. 9, 2019 From the US Patent and Trademark Office Re. U.S. Appl. No. 14/232,573. (13 pages). |
Official Action dated Sep. 8, 2016 From the US Patent and Trademark Office Re. U.S. Appl. No. 14/232,573. (12 pages). |
Official Action dated Sep. 14, 2017 From the US Patent and Trademark Office Re. U.S. Appl. No. 14/232,573. (18 pages). |
Official Action dated Apr. 17, 2017 From the US Patent and Trademark Office Re. U.S. Appl. No. 14/232,573. (18 pages). |
Official Action dated May 17, 2016 From the US Patent and Trademark Office Re. U.S. Appl. No. 14/232,573. (11 pages). |
Official Action dated Sep. 20, 2018 From the US Patent and Trademark Office Re. U.S. Appl. No. 14/232,573. (24 pages). |
Official Action dated Mar. 28, 2018 From the US Patent and Trademark Office Re. U.S. Appl. No. 14/232,573. (19 pages). |
Official Action dated Sep. 28, 2015 From the US Patent and Trademark Office Re. U.S. Appl. No. 14/232,573. (11 pages). |
Supplementary European Search Report and the European Search Opinion dated Feb. 27, 2015 From the European Patent Office Re. Application No. 12811116.8. (8 Pages). |
Written Opinion dated Nov. 11, 2012 From the International Searching Authority Re. Application No. PCT/IL2012/000278. (9 Pages). |
Written Opinion dated Oct. 23, 2012 From the International Searching Authority Re. Application No. PCT/IL2012/000278. (8 Pages). |
Boston Scientific “Reducing the Risk of Stroke in Atrial Fibrillation With the Watchman™ Left Atrial Appendage (LAA) Closure Device”, Boston Scientific, SH-282105-AA, Poster Leaflet, 2 P., Nov. 2014. |
Hu et al. “Device-Based Approach to Prevention of Stroke in Atrial Fibrillation”, The Journal of Innovations in Cardiac Rhythm Management, 6: 2038-2050, Jun. 2015. |
Kreidieh et al. “Left Atrial Appendage Remodeling After Lariat Left Atrial Appendage Ligation”, Circulation Arrhythm Electrophysiology, 8(6): 1351-1358, Published Online Oct. 20, 2015. |
Omran “Left Atrial Appendage Anatomy: The LAA Is Unique as a Fingerprint, How to Close Those Successfully?”, Euro PCR 2016, Slide Show, 37 P., 2016. |
Piccini et al. “Left Atrial Appendage Occlusion: Rationale, Evidence, Devices, and Patient Selection”, European Heart Journal, EHW330: 1-9, Advance Access Pubheation Sep. 13, 2016. |
International Preliminary Report on Patentability dated Oct. 10, 2019 From the International Bureau of WIPO Re. Application No. PCT/IL2018/050353. (14 Pages). |
Official Action dated Mar. 8, 2021 From the US Patent and Trademark Office Re. U.S. Appl. No. 16/497,821. (30 Pages). |
Final Official Action dated Oct. 15, 2021 fromUS Patent and Trademark Office Re. U.S. Appl. No. 16/497,821. (20 pages). |
Number | Date | Country | |
---|---|---|---|
20190321020 A1 | Oct 2019 | US |
Number | Date | Country | |
---|---|---|---|
61457928 | Jul 2011 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 14232573 | US | |
Child | 16408506 | US |